You are here: Industry Insights > Merck

News List

Merck joins Novartis, GlaxoSmithKline in grabbing a consumer executive to beef up digital fiercepharma
October 18, 2018
Merck & Co. is joining the chief digital officer parade. The pharma giant has poached Jim Scholefield from Nike to head up its global IT and digital strategy, becoming the latest Big Pharma to put digital on its priority list....
CPhI recognizes Merck for innovative products biospectrum
October 15, 2018
Company awarded for excellence in innovation for Parteck MXP Excipient and modified amino acids.
Up to 10-years of follow-up data reaffirm safety profile of Mavenclad (cladribine tablets) worldpharmanews
October 12, 2018
Merck, the vibrant science and technology company, today announced the presentation of new data for MAVENCLAD® (cladribine tablets) at the 34th Congress of the European Committee for Treatment and Research In Multiple Sclerosis (ECTRIMS) in Berlin, German
With nod in older adults, Merck drives HPV shot Gardasil 9 into big new market biospectrum
October 09, 2018
With HPV vaccine uptake slow to take off in the U.S. way back when, Merck & Co.'s Gardasil shots missed out on many eligible patients.
Merck bags USFDA approval for 2 new HIV drugs biospectrumasia
September 29, 2018
Since the beginning of the epidemic, more than 70 million people have been infected with the HIV virus and about 35 million people have died of HIV
Merck opens S$20 M lab in Singapore biospectrumasia
September 29, 2018
“The establishment of Merck’s biosafety testing lab will strengthen Singapore’s competitiveness as a leading global site for biologics manufacturing”
Merck and Pfizer trial cancer combination with Australia’s Immutep pharmaphorum
September 27, 2018
Australian biotech Immutep has begun a clinical trial partnership with Germany’s Merck KGaA and Pfizer to develop a new cancer immunotherapy combination therapy.
Immutep collaborates with Merck, Pfizer for Efti biospectrum
September 26, 2018
The clinical trial will evaluate the clinical benefits of releasing the brakes and pushing the accelerator of the body’s immune system at two different positions in the cancer immunity cycle.
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag fiercepharma
September 20, 2018
When Bristol-Myers Squibb unveiled its price for Opdivo in China, industry watchers considered it a benchmark against which future immuno-oncology therapies will look to for their pricing strategies.
Accenture, Merck, Amazon partner to advance drug innovation and research biospectrumasia
September 19, 2018
Accenture and Merck Collaborate with Amazon Web Services to Launch a Research Platform to Drive Innovation in Drug Discovery and Scientific Research

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page